Correlation Between Alkermes Plc and Citius Oncology,
Can any of the company-specific risk be diversified away by investing in both Alkermes Plc and Citius Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alkermes Plc and Citius Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alkermes Plc and Citius Oncology,, you can compare the effects of market volatilities on Alkermes Plc and Citius Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alkermes Plc with a short position of Citius Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alkermes Plc and Citius Oncology,.
Diversification Opportunities for Alkermes Plc and Citius Oncology,
-0.19 | Correlation Coefficient |
Good diversification
The 3 months correlation between Alkermes and Citius is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Alkermes Plc and Citius Oncology, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Oncology, and Alkermes Plc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alkermes Plc are associated (or correlated) with Citius Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Oncology, has no effect on the direction of Alkermes Plc i.e., Alkermes Plc and Citius Oncology, go up and down completely randomly.
Pair Corralation between Alkermes Plc and Citius Oncology,
Given the investment horizon of 90 days Alkermes Plc is expected to generate 0.17 times more return on investment than Citius Oncology,. However, Alkermes Plc is 5.72 times less risky than Citius Oncology,. It trades about 0.08 of its potential returns per unit of risk. Citius Oncology, is currently generating about -0.2 per unit of risk. If you would invest 2,406 in Alkermes Plc on September 1, 2024 and sell it today you would earn a total of 496.00 from holding Alkermes Plc or generate 20.62% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 61.9% |
| Values | Daily Returns |
Alkermes Plc vs. Citius Oncology,
Performance |
| Timeline |
| Alkermes Plc |
| Citius Oncology, |
Alkermes Plc and Citius Oncology, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alkermes Plc and Citius Oncology,
The main advantage of trading using opposite Alkermes Plc and Citius Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alkermes Plc position performs unexpectedly, Citius Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will offset losses from the drop in Citius Oncology,'s long position.| Alkermes Plc vs. Tff Pharmaceuticals | Alkermes Plc vs. Eliem Therapeutics | Alkermes Plc vs. Inhibrx | Alkermes Plc vs. Enliven Therapeutics |
| Citius Oncology, vs. Verve Therapeutics | Citius Oncology, vs. Beam Therapeutics | Citius Oncology, vs. Caribou Biosciences | Citius Oncology, vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |